Dapagliflozin reduces cardiovascular death risk in patients with preserved ejection fraction Read more
ZeNix trial shows effectiveness of BPaL regimen for TB can be maintained with reduced dosing of Linezolid Read more
CHMP recommends EU approval of Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma Read more